The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study.

FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...

The past 12 months have seen the FDA approvals of enfortumab vedotin plus pembrolizumab for patients with locally advanced or ...

Patients on the Tevimbra combo had a 20 percent reduction in risk of death compared to those on chemotherapy alone.

And why didn’t it cut off Russia’s natural gas earlier? By Marc SantoraAndrew Higgins and Stanley Reed A transnational pipeline was shut down on Wednesday after Kyiv refused to renew a ...

In New Orleans, Celebration Is Followed by Terror in the French Quarter The attack left 15 dead and about three dozen injured. The authorities described it as an act ...

Today is also National Science Fiction Day, a date that honors the birth, 105 years ago, of literary sci-fi genius Isaac Asimov. A Russian immigrant ...

The island of Syros in Greece has been voted recently the second most welcoming destination in the world, according to traveler reviews at Booking.com. The Brazilian city of Arraial d'Ajuda, famed for ...